Bringing structural heart patients better clinical outcomes
Clinical evidence demonstrates the benefits of minimally invasive interventions for patients with structural heart diseases. Detailed information and accurate imaging are crucial to support successful structural heart procedures and better outcomes for TAVI, LAAo and emerging TMVR interventions.
Using routine preoperative CT data, FEops HEARTguide™ simulation-based technology takes preoperative planning to the next level by:
- going beyond simple anatomical measurement, surpassing the ‘overlay technique’ currently used to gauge the size and position of the undeformed device;
- accurately predicting how the device will interact with each unique patient, including the effects of positioning;
- providing physicians with detailed insights that assist in the selection of ideal device size and position.
As the first CE-marked product within the FEops HEARTguide™ family, TAVIguide™ helps clinicians select optimal device size and position to avoid aortic regurgitation (PVL) and conduction abnormalities. CE mark for FEops HEARTguide with indication in TAVI and LAAo is expected in the first half of 2019.